A Case Report on Therapeutic Optimization and Cardiometabolic Benefits of Semaglutide Therapy in Type 2 Diabetes Mellitus: Case Report. JOPIR [Internet]. 2026 Apr. 5 [cited 2026 May 19];4(2):252-8. Available from: https://staging.jopir.in/index.php/journals/article/view/742